NCT03172390View on ClinicalTrials.gov

In Vivo Evaluation of Growth and Risk of Rupture of Dilated Ascending Aorta Using 4D Cardiac Magnetic Resonance

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

October 11, 2017

Primary Completion Date

April 11, 2019

Study Completion Date

March 4, 2020

Conditions
Aortic Rupture
Interventions
DEVICE

4D Cardiac Magnetic Resonance

4D Cardiac Magnetic Resonance for patients with a ascending aorta dilatation without current indication for surgery for measured parameters of ascending aorta

Trial Locations (1)

42055

CHU de Saint-Etienne, Saint-Étienne-de-Montluc

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT03172390 - In Vivo Evaluation of Growth and Risk of Rupture of Dilated Ascending Aorta Using 4D Cardiac Magnetic Resonance | Biotech Hunter | Biotech Hunter